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2In 2006, an estimated 6,300 Iowans will die from cancer, 14 times the number caused by auto fatalities. 
Cancer is second only to heart disease as a cause of death. These projections are based upon mortality 
data the State Health Registry of Iowa receives from the Iowa Department of Public Health. The Registry 
has been recording the occurrence of cancer in Iowa since 1973, and is one of fourteen population-based 
registries and three supplementary registries nationwide providing data to the National Cancer Institute.  
In 2006 an estimated 16,000 cancers will be newly diagnosed among Iowa residents. With 2006 Cancer 
in Iowa the Registry makes a general report to the public on the status of cancer. This report will focus on: 
 • a description of the Registry and its goals; 
 • cancer estimates for 2006; 
 • a special section on brain and central nervous system tumors; 
 • brief summaries of recent/ongoing research projects; 
 • a selected list of publications from 2005.



































In 2006, cancer will strike ﬁve out of every 1,000 Iowans. Cancer is the second leading cause of death 
in Iowa, responsible for about 230 of every 1,000 deaths. Breast, colon & rectum, lung, and prostate 









































































































































































































































































































































































































ESTIMATED NUMBER OF CANCER DEATHS IN IOWA FOR 2006
CANCER PROJECTIONS FOR 2006






























































































































































































8Findings from the Iowa Pilot Study
The Iowa study targeted clinically and pathologically conﬁrmed nonmalignant (benign/uncertain) 
behavior brain tumors diagnosed in 2000 that conformed to speciﬁc site and morphology codes. 
Based on the Iowa experience between 1990 and 1996, it was estimated that 210 newly diag-
nosed malignant brain/CNS tumors would be reported during the year 2000. Based on the experi-
ence of other registries, the number of nonmalignant brain/CNS tumors was estimated to be the 
same. The Registry identiﬁed 213 malignant tumors and 274 nonmalignant brain/CNS tumors in 
2000. The breakdown by age and gender is given in Table 1.
TABLE 1.  DISTRIBUTION OF PRIMARY BRAIN/CNS TUMORS DIAGNOSED IN 2000 BY AGE GROUP,  
GENDER AND BEHAVIOR, IOWA
The female-to-male ratio of nonmalignant tumors was 1.5 to 1.0 whereas for malignant tumors  
it was 0.8 to 1.0. Among the nonmalignant tumors, 4% were found in children, 46% in younger 
adults, and 50% in older adults. Among malignant tumors, 18% were found in children, 49% in 
younger adults, and 33% in older adults. Malignant tumors compared with nonmalignant tumors 
more commonly occur in children.  
The most common site for nonmalignant brain tumors was the meninges (36%) followed by neuro-
endocrine and related structures (23%), brain (21%), and spinal cord, cranial nerves & other CNS 
(20%). The three most common subsite locations were the cerebral meninges (28%), pituitary 
gland (21%), and acoustic nerve (15%). For malignant brain tumors, the overwhelmingly common 
site was the brain (91%). The most common speciﬁc subsites of the brain were frontal lobe (16%), 
temporal lobe (16%), overlapping lesion of brain (15%), parietal lobe (9%), and cerebellum (8%).   
The most common morphology code assigned nonmalignant brain/CNS tumors was meningioma 
(46%) followed by pituitary adenoma (20%) and schwannoma (20%). Glioblastoma (38%) was the 
most common malignant tumor.
Of the 274 nonmalignant tumors, 62% were pathologically conﬁrmed and 38% were clinically  
conﬁrmed. The clinically conﬁrmed were done so by radiographic procedures. Of the 213 malignant 
brain tumors, 88% were pathologically conﬁrmed, 8% involved radiography, and 4% involved an 
unspeciﬁed method.  
  %             #                   %           #                   %          #
                                               Brain/CNS Tumor Behavior
Age in years  Gender               Nonmalignant                  Malignant                       Total 
                 
<20 (children) Male 1.1           3  10.3      22  5.2       25  
 Female 3.3          9  8.0      17  5.3       26 
20-64 (younger adults)  Male 21.2       58  28.6      61  24.4     119   
 Female 24.8       68  20.2      43  22.8     111
65+ (older adults) Male 18.2       50  16.0      34  17.2 84 
 Female 31.4       86  16.9      36  25.1     122
All ages Male 40.5     111  54.9    117  46.8    228 
 Female 59.5     163  45.1      96  53.2 259
9RESEARCH PROJECTS DURING 2006
The State Health Registry of Iowa is participating 
in over two dozen funded studies during 2006. 
Brief descriptions of a few of these studies are 
provided.
The Agricultural Health Study
The Agricultural Health Study is a long-term study 
of agricultural exposures and chronic disease 
(especially cancer) among commercial or private 
pesticide applicators (and their spouses, if mar-
ried) in Iowa and North Carolina. The study is 
funded primarily by the National Cancer Institute. 
We are in the 14th year of the study, which 
received renewed funding at the end of 2003 for 
continuation through 2008.  
In the ﬁrst ﬁve years, 89,658 subjects (58,564 in 
Iowa and 31,094 in North Carolina) were enrolled 
in the study.  This total for Iowa included 31,877 
private applicators, 21,771 spouses of private 
applicators, and 4,916 commercial applicators. 
Enrollment consisted of completing question-
naires about past exposures and health.  
The second phase of the study for private appli-
cators and their spouses was completed at the 
end of 2003. It involved a telephone interview, 
a mailed dietary questionnaire, and collection of 
a cheek cell sample from all consenting cohort 
members. The telephone interview asked about 
pesticide use since enrollment, current  
farming and work practices, and health changes.  
The dietary health questionnaire asks about cook-
ing practices and types of foods eaten. Cooking 
practices and diet may play a role in cancer and 
other health conditions. The cheek cells will be 
used to understand possible links between genet-
ics, exposures, and disease. The second phase of 
the study was completed with commercial applica-
tors at the end of 2005. The study’s third phase 
began in 2005 and involves updating information 
about exposures and health.  
Since 1997, cohort members have been linked 
annually to mortality and cancer registry inci-
dence databases in both states. In addition, 
mortality data on the cohort are being obtained 
from the National Death Index. More information 
about recent results from this study, the study 
background, frequently asked questions, other 
resources (internet & telephone) for agricultural 
health information, references for publications 
to date, and information for scientiﬁc collabora-
tors can be found at the website, www.aghealth.
org. The abstract and/or full text are available for 
these publications. The references for some of the 
recent publications are provided in the last section 
of this report.      
Lung Cancer Care Outcomes/Surveillance 
Consortium 
This study involves a coordinating center, the State 
Health Registry of Iowa, and six other primary data 
collection and research sites across the United 
States. Across these sites, we are investigating 
patterns of care for lung cancer, the reasons for 
particular care decisions by patients and their 
physicians, variation in dissemination of modern 
care protocols and practices in different geographic 
areas, and the effects of these decisions and  
practices on patient outcomes, including quality  
of life. We enrolled over 1,000 Iowa residents  
newly diagnosed with lung cancer between June 
2003 and March 2005. We are currently working 
on follow-up interviews and medical record  
abstraction.  
Studies involving Non-Hodgkin Lymphoma (NHL)
The State Health Registry of Iowa with research-
ers at the Mayo Clinic participated in a collabora-
tive, population-based case-control study of NHL 
that also involved researchers at the National 
  %             #                   %           #                   %          #
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Cancer Institute and three other Surveillance, 
Epidemiology, and End Results (SEER) registries. 
The main objective of the study was to better 
characterize risk factors for NHL. In Iowa, 364 
live patients newly diagnosed with NHL between 
July 1, 1998 and June 30, 2000 were enrolled. 
A similar number of population controls partici-
pated. The State Health Registry of Iowa also 
coordinated the acquisition of pathology reports, 
slides and tissue blocks from all SEER centers. 
The slides were reviewed to determine the reli-
ability of NHL pathologic classiﬁcation. More 
recently, we are collaborating with researchers 
at the Mayo Clinic to investigate whether genes 
with functional, common variant polymorphisms 
involved in immune function and regulation are 
associated with overall survival from NHL among 
these patients. The speciﬁc aims are to evaluate: 
1) the association of polymorphisms in selected 
immune-related genes from four key pathways  
on NHL survival that include genes encoding 
inﬂammatory and regulatory cytokines, Th1/Th2  
cytokines, innate immunity, and chemokines;  
2) whether any effects are independent of other 
established NHL prognostic factors (such as  
age and stage) and treatment modalities; and  
3) whether any effects are speciﬁc to diffuse 
large B-cell lymphoma or the combination of  
follicular and small lymphocytic lymphoma.  
To achieve these aims, medical record reviews 
were performed to obtain more detailed informa-
tion on the treatment received for NHL. These 
research activities resulted in several publica-
tions during 2005. The references for these are 
provided in the last section of this report.      
Second Cancer Study of the  
Gastrointestinal System
The Second Cancer Study of the GI System 
includes seven case-control investigations with  
a common primary purpose of evaluating the  
relation between cancer treatment (radiation 
and/or chemotherapy) and cancer risk for three 
gastrointestinal organs (stomach, pancreas, and 
esophagus). Radiation and chemotherapy are 
commonly used as treatment for the ﬁrst primary 
cancers in these investigations (Hodgkin disease, 
cancers of the testis, breast, or cervix). Radiation 
and chemotherapy may be given with the inten-
tion of curing cancer or for cancer control and 
prolonged life. The cumulative effect may include 
a risk of developing treatment-induced cancers. 
The results of this series of studies will help 
determine if current treatment protocols should 
be modiﬁed to control the risk of second cancers 
involving the stomach, pancreas, or esophagus. 
Through 2005, the State Health Registry com-
pleted detailed radiation and chemotherapy data 
collection forms for 90 patients, 30 cases (who 
had one of the four eligible ﬁrst cancers followed 
by one of the three eligible gastrointestinal can-
cers) and 60 controls (who had one of the four 
eligible ﬁrst cancers and none of the eligible gas-
trointestinal cancers). Over the past two decades 
the State Health Registry of Iowa has participated 
in several second cancer studies. These research 
activities have resulted in several publications, 
the most recent of which are provided in the refer-
ences in the last section of this report. 
Using Geographic Information to Interpret 
Cancer Maps  
This research is developing and testing a meth-
odology for identifying regions of excess cancer 
burden for breast and colorectal cancer in Iowa.  
It will reﬁne measures of geographic access 
to cancer prevention, treatment, and screen-
ing services in Iowa by computing values using 
ﬁne-scaled geographic data on individuals, the 
spatial choices of individuals, and the locations 
of service providers. It uses State Health Registry 
of Iowa data for a thirteen-year period and links 
patient ﬁles to Medicare and selected medical 
insurance records. Statistical models are being 
computed to associate speciﬁc cancer burden 
measures to predictor variables that capture local 
characteristics of the area and characteristics of 
the individuals, while maintaining conﬁdentiality.  
A regional simulation workbench is being devel-
oped to generate the expected range and varia-
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tions in the cancer burden measures for small 
geographic areas of Iowa based on local demo-
graphic characteristics of the area and statewide 
cancer burden rates. Results can be used to plan 
more appropriate cancer prevention and control 
programs.
Geographic Information and Prostate Cancer 
This study will focus on reviewing prostate cancer  
geocoding issues in relation to the geographic 
information science principle of “ﬁtness for use”. 
This study will ask “for what purposes are  
prostate cancer incidences geocoded?” and  
“to achieve each purpose, what are the essential 
characteristics of the geocoded prostate cancer 
data?” Our speciﬁc aims include producing an 
edited book of key geocoding issues; preparing  
“A Primer on Geocoding for Prostate Cancer 
Prevention and Control Activities”; conducting 
research and ﬁeld-testing to compare and evalu-
ate different geocoding methods; and developing 
methods, and performing experiments on the  
subject of masking the locations of geocoded 
prostate cancer incidences sufﬁcient to guaran-
tee their conﬁdentiality, yet leaving them ﬁt for 
use for many prostate cancer prevention and  
control purposes.
SEER Patterns of Care Studies
This is a collaborative set of studies between 
the National Cancer Institute and its 14 SEER 
Registries. In 2006, we will investigate state-of-
the-art therapies for male breast cancer; kidney 
cancer; node-negative, estrogen receptor positive, 
female breast cancer; and head and neck cancer. 
Across these cancer sites, 235 patients will be 
eligible at the State Health Registry of Iowa and 
each will have been newly diagnosed during 2004 
(male breast cancer involves 2003 as well).  
The Registry has been involved with these types 
of studies over the past 20 years. The collected 
data have resulted in several publications, some 
of which were published in 2005 and are listed  
in the last section of this report. 
The Iowa Women’s Health Study
This is a population-based cohort of 41,837 Iowa 
women, aged 55-69 in 1986, who were recruited 
to determine whether diet, body fat distribution and 
other risk factors were related to cancer incidence. 
Exposure and lifestyle information was collected  
in a baseline mailed survey and subsequently in  
several follow-up mailed surveys. Mortality and  
cancer incidence have been ascertained since 
1986 through linkage to the State Health Registry 
of Iowa databases and the National Death Index.  
The project has been extremely productive with 
over 150 publications, some of which occurred in 
2005 and are listed in the references provided  
in the last section of this report. This year Registry 
staff will begin obtaining pathologic materials for 
several hundred women in this study who have 
been diagnosed with colorectal cancer (CRC) as 
part of a collaborative study with researchers at 
the Mayo Clinic. The primary aims of the study are 
to examine associations between environmental 
factors and CRC subtypes 1) deﬁned by microsatel-
lite instability phenotype, 2) deﬁned by Ki-ras  
mutation status and p53 mutation status, and  
3) deﬁned by gene-speciﬁc methylation patterns. 
The study will be ongoing for the next several years.  
Cooperative Agreements and Other Registries
The State Health Registry of Iowa maintains coopera-
tive agreements with several hospital cancer regis-
tries and other agencies/entities. Some of the latter 
include: 
• Iowa Department of Public Health 
• Iowa Consortium for Comprehensive Cancer Control 
• The University of Iowa 
 -  Center for Health Effects of Environmental   
   Contamination 
 -  Center for Public Health Statistics 
 -  Environmental Health Sciences Research Center 
 -  Health Effectiveness Research Center 
 -  Holden Comprehensive Cancer Center 
 -  Iowa Center for Agricultural Safety and Health 
 -  Injury Prevention Research Center 
 -  Prevention Intervention Center  
 -  Reproductive Molecular Epidemiology Research  
   & Education Program
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